BTIG analyst Ryan Zimmerman reiterated a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of $91.00. The ...

Jefferies analyst Matthew Taylor maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

Globus said it will offer 33 unique itineraries to Italy in 2025, covering 13 regions, 99 cities and several travel styles.

Fintel reports that on January 9, 2025, B of A Securities upgraded their outlook for Globus Medical (NYSE:GMED) from Underperform to Neutral. Analyst Price Forecast Suggests 12.50% Upside As of ...

Is making friends at work important to you in your job? Researchers say friendships with colleagues can be an important part ...

Globus Spirits Ltd., incorporated in the year 1993 ... Company has reported net profit after tax of Rs 1.28 Crore in latest quarter.The company’s top management includes Mr.Sunil Chadha, Mr.Ajay Kumar ...

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari ...

Stifel analyst Rick Wise said the financing, a combination of private stock placement and new loans, should help the dialysis ...

Globus is offering its most expansive selection of itineraries in Italy in 2025, with 33 different itineraries visiting 13 ...